Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06222593
What this trial is testing

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC

Who this might be right for
Carcinoma, Renal Cell
State University of New York at Buffalo 28
Not applicableActive Not RecruitingNCT07060248
What this trial is testing

A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

Who this might be right for
Renal Cell Carcinoma (RCC)
Second Xiangya Hospital of Central South University 700
Not applicableStudy completedNCT01728948
What this trial is testing

Sorafenib in Elderly mRCC

Who this might be right for
Carcinoma, Renal Cell
Bayer 60
Testing effectiveness (Phase 2)Study completedNCT02535533
What this trial is testing

SLM + Axitinib for Clear Cell RCC

Who this might be right for
Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
Mohammed Milhem 45
Testing effectiveness (Phase 2)Looking for participantsNCT06750185
What this trial is testing

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 248
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022343
What this trial is testing

Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8
Emory University 22
Not applicableStudy completedNCT04033991
What this trial is testing

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Who this might be right for
CarcinomaRenal Cell
Pfizer 684
Early research (Phase 1)Study completedNCT00625768
What this trial is testing

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Malignant Melanoma
Antisoma Research 13
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Not applicableWithdrawnNCT04555603
What this trial is testing

Axitinib Therapy Management Study

Who this might be right for
Renal Cell Carcinoma
Pfizer
Large-scale testing (Phase 3)WithdrawnNCT03693573
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00420888
What this trial is testing

ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Active Biotech AB 526
Testing effectiveness (Phase 2)Study completedNCT03066427
What this trial is testing

Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.

Who this might be right for
Clear Cell Renal Carcinoma
Spanish Oncology Genito-Urinary Group 23
Testing effectiveness (Phase 2)UnknownNCT02330783
What this trial is testing

Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Peking University Cancer Hospital & Institute 106
Not applicableActive Not RecruitingNCT02664883
What this trial is testing

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Who this might be right for
Healthy SubjectMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+3 more
University of Southern California 37
Not applicableStudy completedNCT06020651
What this trial is testing

Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside

Who this might be right for
Renal Cell CarcinomaBladder CancerMSI-H Cancer+1 more
Institut Mutualiste Montsouris 39
Large-scale testing (Phase 3)Study completedNCT01223027
What this trial is testing

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 564
Not applicableWithdrawnNCT01781442
What this trial is testing

A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

Who this might be right for
Renal Cell Carcinoma
Pfizer
Next Page